Top Suppliers:I want be here


138926-19-9

138926-19-9 structure
138926-19-9 structure
  • Name: Ibandronate sodium
  • Chemical Name: Ibandronate Sodium Monohydrate
  • CAS Number: 138926-19-9
  • Molecular Formula: C9H24NNaO8P2
  • Molecular Weight: 359.226
  • Catalog: Organic raw materials Organic phosphine compound
  • Create Date: 2018-03-18 08:00:00
  • Modify Date: 2026-07-02 10:24:09
  • Ibandronate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.Target: OthersIbandronate (1.25-2 μM) significantly reduces endothelial cell growth, while ibandronate (2 μM) also significantly reduces capillary-like tube formation and increases apoptosis of endothelial cells. Ibandronate (< 100 μM) dose-dependently increases VEGF expression in endothelial cells [1]. Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner [2].Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment [3]. Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses [4].

Name Ibandronate Sodium Monohydrate
Synonyms Ibandrate
Phosphonic acid, P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt, hydrate (1:1:1)
Ibandronic acid monosodium salt monohydrate
1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonatemonosodiummonohydrate
Ibandronate sodium hydrate
sodium,hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate,hydrate
Ibandronate Sodium MonohydrateQ: What is Ibandronate Sodium Monohydrate Q: What is the CAS Number of Ibandronate Sodium Monohydrate Q: What is the storage condition of Ibandronate Sodium Monohydrate Q: What e the applications of Ibandronate Sodium Monohydrate
Ibandronate Sodium Hydrate
Ibandronate (Sodium Monohydrate)
IBANDRONATE SODIUM SALT
BM-21.0955 monosodium salt monohydrate
Sodium trihydrogen (1-hydroxy-3-(methylpentylamino)propylidene)diphosphonate, monohydrate.
Phosphonic acid, [1-hydroxy-3-(methylpentylamino)propylidene]bis-, sodium salt, hydrate (1:1:1)
IBANDRONATE SODIUM/1-HYDROXY-3-(METHYLPENTYLAMINO)PROPYLIDENE
Ibandronate sodium monohydrate
{1-hydroxy-3-[Methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid
Ibandronate sodium monohydrate - Bio-X
Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-, monosodium salt, monohydrate
MFCD00912167
Sodium hydrogen(1-hydroxy-3-(methyl(pentyl)amino)-1-phosphonopropyl)phosphonate hydrate
Bondronat monohydrate
Ibronate Sodium
Sodium Trihydrogen (1-Hydroxy-3-(methylpenthylamino)propylidene)diphosphonate Monohydrate
IBANDRONATE SODIUM MONOHYDRATE
Ibandronate sodiuM salt Monhydrate
Ibandromate Monosodium
Ibandronate sodium monohydrate, >=
(1-​Hydroxy-​3-​(methylpentylamino)​propylidene)​bisphosphonic acid sodium
Ibadronate SodiuM
RPR-102289A
[1-Hydroxy-3-(methylpentylamino)propylidene]bisphosphonic acid sodium salt monohydrate
Bonviva
[1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt
BM 21.0955Na.H2O
Sodium hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate hydrate (1:1:1)
BM-21.0955
Boniva
Boniva monohydrate
Description Ibandronate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.Target: OthersIbandronate (1.25-2 μM) significantly reduces endothelial cell growth, while ibandronate (2 μM) also significantly reduces capillary-like tube formation and increases apoptosis of endothelial cells. Ibandronate (< 100 μM) dose-dependently increases VEGF expression in endothelial cells [1]. Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner [2].Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment [3]. Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses [4].
Related Catalog
References

[1]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8.

[2]. Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33.

[3]. Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9.

[4]. Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8.

Boiling Point 587.8ºC at 760 mmHg
Melting Point 84ºC (dec)
Molecular Formula C9H24NNaO8P2
Molecular Weight 359.226
Flash Point 309.3ºC
Exact Mass 359.087494
PSA 170.21000
LogP 0.87390
Vapour Pressure 2.88E-16mmHg at 25°C
Storage condition -20°C Freezer
Hazard Codes Xn: Harmful;
Risk Phrases R40
Safety Phrases 22-36
RIDADR UN 1759 8 / PGIII
HS Code 2922199090

~%

138926-19-9 structure

138926-19-9

Literature: WO2005/63779 A2, ; Page/Page column 6 ;

~%

138926-19-9 structure

138926-19-9

Literature: WO2011/16738 A1, ; Page/Page column 9-10 ;

~%

138926-19-9 structure

138926-19-9

Literature: WO2008/60609 A1, ; Page/Page column 21 ;

~%

138926-19-9 structure

138926-19-9

Literature: WO2008/14510 A2, ; Page/Page column 24-25 ;

~%

138926-19-9 structure

138926-19-9

Literature: WO2008/60609 A1, ; Page/Page column 21 ;

~%

138926-19-9 structure

138926-19-9

Literature: WO2008/60609 A1, ; Page/Page column 22 ;
HS Code 2922199090
Summary 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.